Guidelines help docs manage patients on novel anticoagulants

Kim Carollo | | Cardiovascular Business | Vascular & Endovascular

Although the novel oral anticoagulants (NOACs) dabigatran (Pradaxa, Boehringer Ingelheim), rivaroxaban (Xarelto, Janssen) and apixaban (Eliquis, Bristol-Myers Squibb) offer alternatives to warfarin to prevent strokes in patients with atrial fibrillation, physicians may still need guidance on how to manage them.

In a review published in the January issue of International Journal of Stroke, a group of researchers led by Emer R. McGrath, MB, of National University of Ireland in Galway discussed some of the challenges involved in managing these medications and offered suggestions for their use.

One recommendation was to use heparin anti-Xa levels to measure anticoagulant activity rather than prothombin time/international normalized ratio. The researchers also offered recommendations on managing the drugs in patients with renal impairment, thrombolysis in patients on NOACs having a stroke, starting NOAC therapy after an ischemic stroke, managing intracerebral hemorrhage (ICH) in patients taking NOACs, starting NOACs after ICH, appropriate antidotes and managing NOACs in patients with both atrial fibrillation and arterial disease.

 

 

Kim Carollo,

Contributor

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."